Exciting news! Creyon has been granted another U.S. patent for our AI/machine learning-enabled engineering of therapeutic oligonucleotides. What it covers: Our proprietary method for training machine-learned models to optimize oligonucleotide designs for desired biophysical effects and pharmacological endpoints. Why it matters: This technology allows us to create the data and the models that underlie our ability to engineer potential therapies and improve lead identification efficiency by up to 100-fold over industry peers. What's next: Accelerated development of life-changing treatments for both rare and common diseases. Read our press release to learn more about how we're revolutionizing drug development: https://lnkd.in/e64DYGBM #FutureOfMedicine #AIinHealthcare
Creyon Bio的动态
最相关的动态
-
#ISSCR2024 was full of promise and innovation! ? There was a huge amount of research?and clinical?development on display, especially in the #iPSC space ??. We've distilled all of this down into a couple of trends and innovations worth following, here are our two overarching trends to watch: 1.?Single Cell Technologies, Molecular Insights, and Predictive AI tools 2.?Complex 3D models, and Best Practices on Drug Screening Platforms for Inclusive Therapeutic Developments Did you attend? What were your thoughts? #ISSCR24 #stemcellresearch #celltherapy #sciencemeetsai
-
We’re thrilled to announce Enchant, our state-of-the-art multi-modal transformer for drug discovery. Massive congratulations to the team at Iambic Therapeutics who created this technology. And thanks to technology partners who enabled it: Amazon Web Services (AWS) where all of our data infrastructure lives, NVIDIA for long collaboration on #AI technologies for #drugdiscovery, and Lambda for providing robust compute capacity for training models at scale. There’s plenty to read about what Enchant is and what it achieves. But to highlight one facet: we demonstrate that Enchant exhibits emergent performance on clinical tasks that improves through training on more preclinical laboratory data. https://lnkd.in/erJfTsU7
Introducing Enchant?, our groundbreaking multimodal AI model designed to predict clinical outcomes from the earliest stages of drug discovery. Pushing through the R&D "data wall," Enchant leverages abundant discovery-stage data with small amounts of human data to better predict key clinical properties of drug candidates at the earliest stages of research. See today's white paper and press release describing how our state-of-the-art multi-modal transformer model provides predictive insights into pharmacokinetics and other drug properties to reduce cost and increase the quality of clinical drug candidates. #AI #BioTech #Healthcare #Innovation #Enchant https://lnkd.in/gdd5zsRy https://lnkd.in/gzxhcb4H
-
-
Artificial Intelligence is transforming biotech and healthcare by accelerating processes that once took decades and cost billions. AI's ability to analyze vast genomic datasets allows for faster identification of drug targets, while its predictive modeling simulates compound interactions with biological systems, reducing costly trial errors. AI also automates high-throughput screening, speeding up the discovery of viable drug candidates. This technology is driving the future of personalized medicine, where treatments are tailored to individual genetic profiles, leading to better outcomes and fewer adverse effects. The role of AI in biotech is paving the way for faster, more efficient drug development and groundbreaking advances in patient care. #AIinHealthcare #Biotech #DrugDiscovery #PersonalizedMedicine #CBDW #HealthTech #FutureOfMedicine #AIDrivenSolutions #1606Corp CBDWAI
-
-
A new AI-powered tool, TopoFormer, is transforming 3D molecular data into actionable insights for drug development. This breakthrough significantly accelerates the discovery process and reduces costs, making new treatments more accessible. By converting complex structures into simple data for AI models, TopoFormer enables more accurate predictions of drug efficacy. #iworkforComcast #Healthcare #DrugDevelopment #ArtificialIntelligence https://lnkd.in/gsYYBrJt
-
Artificial Intelligence is transforming biotech and healthcare by accelerating processes that once took decades and cost billions. AI's ability to analyze vast genomic datasets allows for faster identification of drug targets, while its predictive modeling simulates compound interactions with biological systems, reducing costly trial errors. AI also automates high-throughput screening, speeding up the discovery of viable drug candidates. This technology is driving the future of personalized medicine, where treatments are tailored to individual genetic profiles, leading to better outcomes and fewer adverse effects. The role of AI in biotech is paving the way for faster, more efficient drug development and groundbreaking advances in patient care. #AIinHealthcare #Biotech #DrugDiscovery #PersonalizedMedicine #CBDW #HealthTech #FutureOfMedicine #AIDrivenSolutions #1606Corp CBDWAI
-
-
We've developed a closed loop discovery system that merges molecular design prowess with biological assay data. This allows us to iteratively construct high precision predictive models, enhancing the efficiency and accuracy of drug discovery. Learn more about how our integrated system is advancing small molecule drug development on our website. https://okt.to/2H1YT5 #Logica #AI #drugdiscovery #LogicaAI
-
-
#NEWS from our Portfolio Company: ? GNQ Insilico's #AI-Driven #DigitalTwins Platform Shows Promising Results in Simulating the Effects of a Drug on Synthesized Digital Twins Sudhir Saxena, CTO of GNQ Insilico comments: "Human clinical trials are often hindered by variability in how patients respond to drugs. Our AI-driven digital twins platform will enable us to better optimize the trial design for precise patient subpopulations, before ever running an expensive clinical trial." Read more: ?? https://lnkd.in/gk8fbD-5 #artificialintelligence #healthtech #medtech #investingnews #healthcare #biotech #ai #generativeai #quantumcomputing #healthcareinnovation #clinicaltrials #stocks #aistocks #healthtechstocks #trenchanttechnologiescapital #trenchant #aitt #aittf
-
-
Product Marketing Expert at SAS. Love B2B marketing and using my expertise to help companies get the most value from Internet of Things (IoT) investments through the power of AI & advanced analytics.
Discover the transformative power of #GenAI in life sciences! Dive into our on-demand webinar featuring industry thought leaders discussing how Gen AI can revolutionize drug development. ?? Watch now to explore the potential and accelerate breakthroughs. https://2.sas.com/6043d8bdb
-
-
Business Development & Regulatory Executive | M. Pharm in Drug Regulatory Affairs | Sudarshan Pharma Ind. Ltd. | Passionate About Pharma Growth & Compliance
Excited ?? to share the publication of my first review paper in the Journal Drug and Drug Candidates, MDPI: 'Revolutionizing Drug Discovery: A Comprehensive Review of AI Applications.' Explore how artificial intelligence is transforming every aspect of drug development, from target identification to toxicity assessment. Special thanks to Dr. Atmaram Pawar sir and Dr. Ankit Ganeshpurkar sir for their invaluable guidance and support throughout this journey. This review delves into the role of AI in compound screening, drug design, and optimization, with insightful data analysis and real-world case studies. Join me in celebrating the intersection of AI and drug discovery, as we navigate through challenges and limitations while paving the way for innovative solutions. #MDPI #DDC #AIinDrugDiscovery #DrugDiscovery #ArtificialIntelligence #Gratitude
-
Global Head of Epidemiology, RWE & Observational Research and Data Ethics Ambassador at SAS, driving ethical and responsible innovation.
Discover the transformative power of #GenAI in life sciences! Dive into our on-demand webinar featuring industry thought leaders discussing how Gen AI can revolutionize drug development. ?? Watch now to explore the potential and accelerate breakthroughs. https://2.sas.com/6041eUXsD
-
